StockFame
  • Trending News
  • Markets
  • US Markets
  • Indian Stocks
  • Economics
  • Crypto News
Select Page
20% Upper Circuit: Infra stock skyrockets after securing an order worth ₹21 Cr

20% Upper Circuit: Infra stock skyrockets after securing an order worth ₹21 Cr

by Trade Brains | January 8, 2026 3:14 pm | Indian Stocks, Market, News

Synopsis: The shares of this company, after many days of sideways momentum, surged today by 20 percent after it reported a work order worth Rs 21.53 crore in the district of  Sabarkantha. The shares of this company, which is engaged in civil constructions and...

Merger: Cigarette stock jumps 4% after appointing Deloitte as advisor for proposed merger scheme

by Trade Brains | January 8, 2026 3:11 pm | Indian Stocks, Market, News

SYNOPSIS: Elitecon International plans a strategic merger of agro and cryogenic businesses, appointing Deloitte as advisor, aiming to enhance scale, efficiency, balance-sheet strength, and long-term shareholder value. During Thursday’s trading session, shares of a...
Bulk Deal: Stock hits 5% upper circuit after Vijay Kedia sold stake in the company

Bulk Deal: Stock hits 5% upper circuit after Vijay Kedia sold stake in the company

by Trade Brains | January 8, 2026 3:10 pm | Indian Stocks, Market, News

Synopsis: Vijay Kedia’s firm sold Mangalam Drugs via bulk deals, selling 1.38 lakh shares. Other participants included Neo Apex, Epitome Trading, and Multiplier Advisors. The total bulk deal value reached Rs. 1.62 crore, while the stock hit 5% upper circuit. This...
SEBI vs Bank of America: Did BofA breach any rules in the Aditya Birla AMC 2024 deal?

SEBI vs Bank of America: Did BofA breach any rules in the Aditya Birla AMC 2024 deal?

by Trade Brains | January 8, 2026 3:10 pm | Indian Stocks, Market, News

Synopsis: SEBI says Bank of America violated market rules during Aditya Birla Sun Life AMC’s 2024 share sale worth $180 million. SEBI highlighted some lapses involving confidential information, which is prohibited from being shared with others, while   The shares of...
Is there any hope for investors in loss-making new-age companies like Paytm, Swiggy and others?

Is there any hope for investors in loss-making new-age companies like Paytm, Swiggy and others?

by Trade Brains | January 8, 2026 2:31 pm | Indian Stocks, Market, News

Synopsis: As Paytm, Swiggy, Meesho, and PhysicsWallah scale rapidly across India’s consumer-tech landscape, a critical question looms: can growth translate into sustainable pricing power before investors lose patience? Despite expanding user bases and rising revenues,...
Penny stock hits upper circuit as the company moves to withdraw insolvency proceedings

Penny stock hits upper circuit as the company moves to withdraw insolvency proceedings

by Trade Brains | January 8, 2026 2:30 pm | Indian Stocks, Market, News

Synopsis: Dharan Infra-EPC Limited has taken a key step toward coming out of insolvency after settling all its dues with its main lender. The company’s suspended board has responded to have fully repaid Tata Capital Housing Finance, leading to further developments....
Agro stock hits 5% upper circuit after its net profit grows 8,587% YoY in 9MFY26

Agro stock hits 5% upper circuit after its net profit grows 8,587% YoY in 9MFY26

by Trade Brains | January 8, 2026 2:29 pm | Indian Stocks, Market, News

Synopsis: This agriculture stock hit an upper circuit, soon after the company announced its Q3 stating the company turning profitable after being loss making for the past quarters. A micro cap company that apart from trading in Agricultural tools and equipment also...
UPL Share price: Can Advanta Unlock Hidden Value and Boost Returns for Shareholders?

UPL Share price: Can Advanta Unlock Hidden Value and Boost Returns for Shareholders?

by Trade Brains | January 8, 2026 1:20 pm | Indian Stocks, Market, News

Synopsis: UPL’s subsidiary Advanta, with 23% EBITDA CAGR and 18% revenue growth, is driving value through expansions in Vietnam and potential listing, supporting UPL’s growth and returns, while HSBC maintains a “Buy” rating with a Rs. 925 target. This company is...
Pharma stock jumps 10% after receiving approval to sell paracetamol in European markets

Pharma stock jumps 10% after receiving approval to sell paracetamol in European markets

by Trade Brains | January 8, 2026 1:20 pm | Indian Stocks, Market, News

Synopsis: The shares of Medicamen Biotech Ltd jumped 10% in two days following the approval of the EU registration for paracetamol from the Danish Medicines Authority. The clearance opens access to regulated European markets, strengthens its export-led growth...
Defence stock jumps 3% after receiving ₹11 Cr order from NewSpace India

Defence stock jumps 3% after receiving ₹11 Cr order from NewSpace India

by Trade Brains | January 8, 2026 1:19 pm | Indian Stocks, Market, News

Synopsis:- Shares gained over 3% after securing a ₹11.19 crore defence order for Xponder systems, boosting medium-term visibility till July 2026. An earlier ₹1.76 crore order, strong defence and space clientele, and long-term government engagements continue to support...

7:5 Bonus Issue: Watch Manufacturing Stock in Focus After Announcing Bonus Shares

by Trade Brains | January 8, 2026 1:16 pm | Indian Stocks, Market, News

Synopsis: The company’s shares are in focus after it announced a bonus issue worth ₹6.85 crore in the ratio of 7:5, to be allotted to shareholders whose names appear on the record date, which will be announced later. The shares of this company, which is engaged in...
Why did DEE Development shares soar 13% today?

Why did DEE Development shares soar 13% today?

by Trade Brains | January 8, 2026 12:25 pm | Indian Stocks, Market, News

Synopsis: DEE Development Engineers Limited reported a December 2025 order book of Rs. 1,302.73 crore, with healthy inflows, strong execution momentum, and additional L1 orders supporting stable revenue visibility. This small-cap stock, engaged in designing,...
Punjab National Bank stock in focus after it puts over ₹760 Cr bad loans on the block again

Punjab National Bank stock in focus after it puts over ₹760 Cr bad loans on the block again

by Trade Brains | January 8, 2026 12:25 pm | Indian Stocks, Market, News

SYNOPSIS: Punjab National Bank is accelerating balance-sheet clean-up by selling large corporate bad loans, a relatively rare move, as it seeks to reduce legacy stress and strengthen financial health amid cautious lending trends. During Thursday’s morning trading...
IRB Infra Share: How much did the company’s toll revenue increase in December 2025?

IRB Infra Share: How much did the company’s toll revenue increase in December 2025?

by Trade Brains | January 8, 2026 12:24 pm | Indian Stocks, Market, News

Synopsis: IRB Infrastructure Developers reported a strong performance in December 2025, with its aggregate toll revenue rising by around 12 percent year-on-year, supported by steady traffic growth across its road portfolio.  The shares of one of the leading highway...
Pharma stock jumps 9% after successfully completing Phase III trial of its dengue vaccine

Pharma stock jumps 9% after successfully completing Phase III trial of its dengue vaccine

by Trade Brains | January 8, 2026 12:23 pm | Indian Stocks, Market, News

Synopsis: Panacea Biotech jumped sharply after the company completed enrollment for the Phase III trial of its dengue vaccine, DengiAll®, with over 10,000 participants. The shares of this research-based biotechnology company are in focus after it announced a key...

Logistics stock jumps 9% as it expands into rail based liquid chemical transportation

by Trade Brains | January 8, 2026 12:21 pm | Indian Stocks, Market, News

Synopsis: AVG Logistics surged 9% on the declaration of foraying into the transportation of liquid chemicals through the rail mode. The newly introduced vertical ISO tank can ensure an annual revenue stream of Rs 22-24 crore per train, marking an addition to the...
Gland Pharma jumps 5% after receiving USFDA approval for Olopatadine Eye Drops

Gland Pharma jumps 5% after receiving USFDA approval for Olopatadine Eye Drops

by Trade Brains | January 8, 2026 12:20 pm | Indian Stocks, Market, News

Synopsis: Gland Pharma shares rose up to 5% after the USFDA approved its Olopatadine Hydrochloride 0.7% ophthalmic solution, expanding its ophthalmic generics portfolio, equivalent to Alcon’s Pataday. The shares of Pharma Company, specialising in manufacturing generic...
Chemical stock jumps 12% after receiving ₹258 Cr incentives from Maha Govt for expansion

Chemical stock jumps 12% after receiving ₹258 Cr incentives from Maha Govt for expansion

by Trade Brains | January 8, 2026 12:19 pm | Indian Stocks, Market, News

Synopsis:- Shares jumped nearly 12% after approval of ₹258 crore state incentives for a mega expansion. Benefits include SGST refunds, power and stamp duty exemptions. A ₹750 crore expansion plan, exports of ₹166 crore and presence across 50+ countries strengthened...
Chemical stock to buy now for an upside of 26%; Recommended by ICICI Direct

Chemical stock to buy now for an upside of 26%; Recommended by ICICI Direct

by Trade Brains | January 8, 2026 11:26 am | Indian Stocks, Market, News

Synopsis:- A brokerage has issued a Buy call with a target of  Rs 5,365, implying 26% upside. The green-chemicals player benefits from 50+ years of expertise, a diversified base of 5,400+ end users across 80+ countries, and expansion plans backed by  Rs 750 crore...
Kaze.ai vs Traditional Image Editing: Which AI Tool Is Right for Your Creative Workflow?

Kaze.ai vs Traditional Image Editing: Which AI Tool Is Right for Your Creative Workflow?

by Trade Brains | January 8, 2026 10:26 am | Indian Stocks, Market, News

In today’s digital-first world, visual content isn’t just eye-catching, it’s also essential. From social media marketing to e-commerce branding and personal portfolios, compelling images can make or break engagement. But not everyone has access to professional design...
« Older Entries
Next Entries »

Recent Posts

  • Liberty Gold Reports Year-End 2025 Financial and Operating Results
  • Baylin Announces Financial Results for Fiscal 2025
  • Draganfly Stock Sheds 21% Post-Earnings — Here’s Why It’s Still A Buy
  • JBS reports record revenue of US$ 86.2 billion and closes 2025 with US$ 2 billion in net income
  • Rep. Seth Moulton bans staff from using prediction markets like Kalshi, Polymarket

About Stockfame

Stockfame is a global media platform delivering bold insights on business, markets, technology, leadership, and entrepreneurship. We bring you research-backed news and sharp analysis to help you stay ahead of the curve.

Quick News Links

  • Crypto News
  • Indian Stocks
  • Latest Posts
  • Market
  • News
  • Trending News
  • US Markets

Contact Us

Reach out to us at:
Phone:  [+91] 9834938257
Email: contact@stockfame.com
For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at contact@stockfame.com

Quick Reads

  • Global market news
  • Crypto Market News
  • Indian Market News
  • Economy News
  • Latest Business News
  • About
  • Terms and Conditions
  • Privacy Policy
  • Website User Agreement
  • Disclaimer
  • Facebook
  • X
  • Instagram
  • RSS
Copyright @StockFame | All Rights Reserved